PHIO
Price:
$1.76
Market Cap:
$1.86M
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collabo...[Read more]
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
PHIO
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -3532813.00. This represents a change of 11.93% compared to the average of -3156348.03 of the last 4 quarters.
The mean historical Enterprise Value of Phio Pharmaceuticals Corp. over the last ten years is 716.67K. The current -3532813.00 Enterprise Value has changed -49394.86% with respect to the historical average. Over the past ten years (40 quarters), PHIO's Enterprise Value was at its highest in in the December 2014 quarter at 26.63M. The Enterprise Value was at its lowest in in the December 2021 quarter at -10241048.00.
Average
716.67K
Median
-4246720.60
Minimum
-12559619.32
Maximum
26.63M
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 758.60%
Maximum Annual Enterprise Value = 26.63M
Minimum Annual Increase = -240.30%
Minimum Annual Enterprise Value = -12559619.32
Year | Enterprise Value | Change |
---|---|---|
2023 | -6874960.00 | 7.31% |
2022 | -6406931.38 | -41.46% |
2021 | -10944128.00 | 758.60% |
2020 | -1274655.36 | -38.91% |
2019 | -2086509.82 | -83.39% |
2018 | -12559619.32 | -240.30% |
2017 | 8.95M | -210.65% |
2016 | -8090026.35 | -140.82% |
2015 | 19.82M | -25.59% |
2014 | 26.63M | 17.61% |
The current Enterprise Value of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-8075339.79
5-year avg
-5517436.91
10-year avg
716.67K
Phio Pharmaceuticals Corp.’s Enterprise Value is greater than Zura Bio Limited (-39351752.00), greater than Apexigen, Inc. (-5121682.00), less than eFFECTOR Therapeutics, Inc. (4.74M), less than Immix Biopharma, Inc. (41.09M), less than CNS Pharmaceuticals, Inc. (-733373.00), less than ZyVersa Therapeutics, Inc. (2.55M), less than VectivBio Holding AG (848.58M), greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4359535.00), less than Ocean Biomedical, Inc. (35.24M), less than Elevation Oncology, Inc. (17.11M), less than Sonnet BioTherapeutics Holdings, Inc. (4.67M), less than 180 Life Sciences Corp. (3.96M), less than Cardio Diagnostics Holdings, Inc. (38.12M),
Company | Enterprise Value | Market cap |
---|---|---|
-39351752.00 | $148.87M | |
-5121682.00 | $9.57M | |
4.74M | $941.00 | |
41.09M | $59.69M | |
-733373.00 | $6.21M | |
2.55M | $2.67M | |
848.58M | $1.06B | |
-85302404.00 | $5.24M | |
-4359535.00 | $1.57M | |
35.24M | $23.12M | |
17.11M | $34.29M | |
4.67M | $4.69M | |
3.96M | $3.68M | |
38.12M | $39.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Phio Pharmaceuticals Corp.'s Enterprise Value?
What is the highest Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
What is the 3-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
What is the 5-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
How does the current Enterprise Value for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?